{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:20:30Z","timestamp":1792095630368,"version":"4.4.0"},"reference-count":58,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Scientific and Technological Developing Plan of Jilin Province","award":["YDZJ202201ZYTS098"],"award-info":[{"award-number":["YDZJ202201ZYTS098"]}]},{"name":"the 4th National Natural Science Foundation of China Continuously Supported Fund","award":["04047200001"],"award-info":[{"award-number":["04047200001"]}]},{"name":"Jilin Provincial Department of Education Scientific Research Project","award":["JJKH20231213KJ"],"award-info":[{"award-number":["JJKH20231213KJ"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901591"],"award-info":[{"award-number":["81901591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273186"],"award-info":[{"award-number":["82273186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,10,1]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The tolerization of plasmacytoid dendritic cells (pDCs) within the tumor microenvironment facilitates immune evasion, thereby significantly limiting the efficacy of cancer immunotherapy. Metabolic regulators are crucial in determining immune cell fate. However, the specific metabolic modifications influencing tumor-associated pDCs (TA-pDCs) are largely uncharacterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We isolated TA-pDCs from patients with colon cancer and mouse models for RNA sequencing detection and immunofluorescence staining. Further, in vitro and in vivo models of colon cancer were used to explore the underlying mechanisms of the fatty acid oxidation (FAO) regulatory pathway of TA-pDCs and its immunosuppressive function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Peroxisome proliferator-activated receptor gamma pathway promotes FAO in TA-pDCs by upregulating the expression of carnitine palmitoyltransferase-1A (CPT1A). The inhibition of CPT1A significantly reduced the immunosuppressive checkpoint inducible co-stimulator ligand (ICOSL) and increased the levels of the immune-activating protein OX40L and pro-inflammatory cytokines interferon-\u03b1 and tumor necrosis factor-\u03b1. These alterations enhanced CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell functionality and diminished the generation of regulatory T cells, thereby bolstering antitumor immunity. The efficacy of combined immunotherapy using anti-ICOSL and anti-programmed cell death 1-ligand 1 antibodies was markedly improved in murine models of colon cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings elucidate the molecular mechanism of CPT1A-mediated FAO in TA-pDCs and its implications in immune evasion, suggesting a novel therapeutic strategy for colon cancer immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-012162","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:15:14Z","timestamp":1761286514000},"page":"e012162","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["CPT1A inhibition alleviates plasmacytoid dendritic cell-mediated immune suppression in colon cancer through fatty acid oxidation modulation"],"prefix":"10.1136","volume":"13","author":[{"given":"Jing","family":"Wu","sequence":"first","affiliation":[{"name":"Cancer Center, The First Hospital of Jilin University, Changchun, China"},{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Cancer Center, The First Hospital of Jilin University, Changchun, China"},{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxia","family":"Zang","sequence":"additional","affiliation":[{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Stomach Colorectal Anal Surgery, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yang","sequence":"additional","affiliation":[{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qiao","sequence":"additional","affiliation":[{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Wei","sequence":"additional","affiliation":[{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Ren","sequence":"additional","affiliation":[{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4720-4225","authenticated-orcid":false,"given":"Jingtao","family":"Chen","sequence":"additional","affiliation":[{"name":"Cancer Center, The First Hospital of Jilin University, Changchun, China"},{"name":"Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"2026052722305877000_13.10.e012162.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00046"},{"key":"2026052722305877000_13.10.e012162.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.01.003"},{"key":"2026052722305877000_13.10.e012162.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.12.018"},{"key":"2026052722305877000_13.10.e012162.4","doi-asserted-by":"publisher","DOI":"10.1038\/S41568-020-0285-7"},{"key":"2026052722305877000_13.10.e012162.5","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001813","article-title":"Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer","volume":"9","author":"Kie\u00dfler","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026052722305877000_13.10.e012162.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.601611","article-title":"Correlation Between Immune Lymphoid Cells and Plasmacytoid Dendritic Cells in Human Colon Cancer","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"2026052722305877000_13.10.e012162.7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2023.04.029","article-title":"Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis","volume":"165","author":"Guo","year":"2023","journal-title":"Gastroenterology"},{"key":"2026052722305877000_13.10.e012162.8","doi-asserted-by":"publisher","DOI":"10.1038\/ni1141"},{"key":"2026052722305877000_13.10.e012162.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01167-5"},{"key":"2026052722305877000_13.10.e012162.10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-090122-041105"},{"key":"2026052722305877000_13.10.e012162.11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131992"},{"key":"2026052722305877000_13.10.e012162.12","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI121421","article-title":"E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs","volume":"128","author":"Bi","year":"2018","journal-title":"J Clin Invest"},{"key":"2026052722305877000_13.10.e012162.13","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1158\/0008-5472.CAN-22-1199","article-title":"Postoperative Plasmacytoid Dendritic Cells Secrete IFN\u03b1 to Promote Recruitment of Myeloid-Derived Suppressor Cells and Drive Hepatocellular Carcinoma Recurrence","volume":"82","author":"Pang","year":"2022","journal-title":"Cancer Res"},{"key":"2026052722305877000_13.10.e012162.14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3468"},{"key":"2026052722305877000_13.10.e012162.15","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03121-9","article-title":"Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling","volume":"43","author":"Monti","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"2026052722305877000_13.10.e012162.16","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.14"},{"key":"2026052722305877000_13.10.e012162.17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2271"},{"key":"2026052722305877000_13.10.e012162.18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2021.09.022","article-title":"Plasmacytoid dendritic cells recruited by HIF-1\u03b1\/eADO\/ADORA1 signaling induce immunosuppression in hepatocellular carcinoma","volume":"522","author":"Pang","year":"2021","journal-title":"Cancer Lett"},{"key":"2026052722305877000_13.10.e012162.19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010753","article-title":"RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells","volume":"13","author":"Pilard","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026052722305877000_13.10.e012162.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.001"},{"key":"2026052722305877000_13.10.e012162.21","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.70"},{"key":"2026052722305877000_13.10.e012162.22","doi-asserted-by":"crossref","first-page":"107926","DOI":"10.1016\/j.compbiomed.2024.107926","article-title":"Single-cell RNA-seq reveals the metabolic status of immune cells response to immunotherapy in triple-negative breast cancer","volume":"169","author":"Liu","year":"2024","journal-title":"Comput Biol Med"},{"key":"2026052722305877000_13.10.e012162.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-022-01002-x"},{"key":"2026052722305877000_13.10.e012162.24","doi-asserted-by":"publisher","DOI":"10.1038\/nri3771"},{"key":"2026052722305877000_13.10.e012162.25","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2172"},{"key":"2026052722305877000_13.10.e012162.26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02927","article-title":"Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Immunol"},{"key":"2026052722305877000_13.10.e012162.27","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaa036"},{"key":"2026052722305877000_13.10.e012162.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.12.018"},{"key":"2026052722305877000_13.10.e012162.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00471-8"},{"key":"2026052722305877000_13.10.e012162.30","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0261"},{"key":"2026052722305877000_13.10.e012162.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-00849-9","article-title":"The activation of PPAR\u03b3 enhances Treg responses through up-regulating CD36\/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of T\u03b2RII\/IL-2R\u03b1","volume":"20","author":"Miao","year":"2022","journal-title":"Cell Commun Signal"},{"key":"2026052722305877000_13.10.e012162.32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/08923973.2019.1616754","article-title":"Inhibition of fatty acid metabolism by etomoxir or TOFA suppresses murine dendritic cell activation without affecting viability","volume":"41","author":"Qiu","year":"2019","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2026052722305877000_13.10.e012162.33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ijc.33777","article-title":"Fatty acid-binding protein 5 limits the generation of Foxp3+ regulatory T cells through regulating plasmacytoid dendritic cell function in the tumor microenvironment","volume":"150","author":"Kobayashi","year":"2022","journal-title":"Int J Cancer"},{"key":"2026052722305877000_13.10.e012162.34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300947"},{"key":"2026052722305877000_13.10.e012162.35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.1.207"},{"key":"2026052722305877000_13.10.e012162.36","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"key":"2026052722305877000_13.10.e012162.37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.607622","article-title":"Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma","volume":"10","author":"Xiao","year":"2020","journal-title":"Front Oncol"},{"key":"2026052722305877000_13.10.e012162.38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2023.04.013","article-title":"Tumor-infiltrating mast cells stimulate ICOS+ regulatory T cells through an IL-33 and IL-2 axis to promote gastric cancer progression","volume":"57","author":"Lv","year":"2024","journal-title":"J Adv Res"},{"key":"2026052722305877000_13.10.e012162.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.12.004"},{"key":"2026052722305877000_13.10.e012162.40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151596","article-title":"Targeting fatty acid \u03b2-oxidation impairs monocyte differentiation and prolongs heart allograft survival","volume":"7","author":"Zhu","year":"2022","journal-title":"JCI Insight"},{"key":"2026052722305877000_13.10.e012162.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.08.015"},{"key":"2026052722305877000_13.10.e012162.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.11.014"},{"key":"2026052722305877000_13.10.e012162.43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051529","article-title":"The CD36-PPAR\u03b3 Pathway in Metabolic Disorders","volume":"19","author":"Mar\u00e9chal","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026052722305877000_13.10.e012162.44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0405928102"},{"key":"2026052722305877000_13.10.e012162.45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501557"},{"key":"2026052722305877000_13.10.e012162.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.06.006"},{"key":"2026052722305877000_13.10.e012162.47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1307"},{"key":"2026052722305877000_13.10.e012162.48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01878","article-title":"Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells","volume":"10","author":"Raychaudhuri","year":"2019","journal-title":"Front Immunol"},{"key":"2026052722305877000_13.10.e012162.49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009720","article-title":"Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis","volume":"12","author":"Daveri","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026052722305877000_13.10.e012162.50","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0384-z"},{"key":"2026052722305877000_13.10.e012162.51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20132000"},{"key":"2026052722305877000_13.10.e012162.52","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-0905-x","article-title":"Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer","volume":"14","author":"Kini Bailur","year":"2016","journal-title":"J Transl Med"},{"key":"2026052722305877000_13.10.e012162.53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semcancer.2022.02.010","article-title":"Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer","volume":"86","author":"Wang","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"2026052722305877000_13.10.e012162.54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101159"},{"key":"2026052722305877000_13.10.e012162.55","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1158\/1078-0432.CCR-24-0385","article-title":"Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF","volume":"30","author":"Bonfill-Teixidor","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2026052722305877000_13.10.e012162.56","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.mucimm.2024.03.013","article-title":"Interferon regulatory factor 6 (IRF6) determines intestinal epithelial cell development and immunity","volume":"17","author":"Wright","year":"2024","journal-title":"Mucosal Immunol"},{"key":"2026052722305877000_13.10.e012162.57","doi-asserted-by":"publisher","DOI":"10.1126\/science.1188510"},{"key":"2026052722305877000_13.10.e012162.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.05.012"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-012162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:31:39Z","timestamp":1779946299000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-012162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,23]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/jitc-2025-012162"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-012162","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}